Mesothelioma, Chemotherapy, Pemetrexed, Platinum, Second-line
Limited-stage, Small Cell Lung Cancer, Amrubicin, Cisplatin, Accelerated, Hyperfractionated, radiotherapy
osimertinib, non-small cell lung cancer, epidermal growth factor receptor, resistance mechanism, circulating tumour DNA